Published in Clin Diagn Lab Immunol on November 01, 1999
Maternal transfer of antibodies in vertebrates: trans-generational effects on offspring immunity. Philos Trans R Soc Lond B Biol Sci (2009) 1.80
Vaccination recommendations for Germany. Dtsch Arztebl Int (2011) 0.97
Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006. Clin Vaccine Immunol (2008) 0.92
Measles outbreak investigation in Zaka, Masvingo Province, Zimbabwe, 2010. BMC Res Notes (2012) 0.88
Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol (2014) 0.86
Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine. J Clin Microbiol (2006) 0.86
The decline of adult smallpox in eighteenth-century London. Econ Hist Rev (2011) 0.85
The epidemiological and serological characteristics of measles in Dongguan, China, 2005-2014. Hum Vaccin Immunother (2016) 0.80
Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants. J Korean Med Sci (2016) 0.79
Transplacental transfer of macromolecules: proving the efficiency of placental transfer of maternal measles antibodies in mother: infant pairs. Ann Med Health Sci Res (2014) 0.77
Opportunities and challenges of Integral Projection Models for modelling host-parasite dynamics. J Anim Ecol (2015) 0.77
Maternal mumps antibodies in a cohort of children up to the age of 1 year. Eur J Pediatr (2012) 0.76
Prevalence of protective measles virus antibody levels in umbilical cord blood samples in Catalonia, Spain. Clin Vaccine Immunol (2010) 0.75
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine. PLoS One (2013) 0.75
Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0-8 months and a control population aged 9-23 months presenting with measles-like symptoms in selected hospitals in Kaduna State. Int J Gen Med (2015) 0.75
Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic. PLoS One (2017) 0.75
Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B Cells. Front Immunol (2017) 0.75
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) (1983) 4.27
Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med (1985) 1.68
Epidemic measles in a highly vaccinated population. N Engl J Med (1977) 1.54
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiol Infect (1988) 1.50
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J Infect Dis (1997) 1.24
Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J Pediatr (1979) 1.17
An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis (1996) 1.14
Maternally derived measles immunity in era of vaccine-protected mothers. J Pediatr (1986) 1.13
Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics (1995) 1.03
Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J (1992) 1.01
The British Standard for anti-rubella serum. J Biol Stand (1975) 1.01
Loss of maternal measles antibody during infancy in an African city. Int J Epidemiol (1989) 0.98
Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft. J Epidemiol Community Health (1995) 0.94
A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect (1996) 0.94
Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months. Epidemiol Infect (1995) 0.93
The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme. Eur J Epidemiol (1995) 0.90
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Schweiz Med Wochenschr (1998) 0.85
Measles--United States, 1992. MMWR Morb Mortal Wkly Rep (1993) 0.85
ESEN: a comparison of vaccination programmes - Part three : measles mumps and rubella. Euro Surveill (1998) 0.85
Measles antibodies in women and infants in the vaccine era. J Med Virol (1995) 0.84
The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. Eur J Epidemiol (1996) 0.83
Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Eur J Epidemiol (1997) 0.83
Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles. Pediatrics (1996) 0.82
Trends in importation of measles to the United States, 1986-1994. JAMA (1997) 0.82
Loss of maternal measles antibody in black South African infants in the first year of life--implications for age of vaccination. S Afr Med J (1991) 0.82
Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Pediatr Infect Dis J (1995) 0.81
Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Pediatrics (1994) 0.81
Measles outbreak--Southwestern Utah, 1996. MMWR Morb Mortal Wkly Rep (1997) 0.81
Measles in Germany. Euro Surveill (1997) 0.79
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1994) 2.94
Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluation. Arthritis Rheum (1982) 2.45
Evaluation of the COBAS AMPLICOR MTB system. J Clin Microbiol (1997) 1.86
Improved performance of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test when 500 instead of 50 microliters of decontaminated sediment is used. J Clin Microbiol (1996) 1.52
Three-step isolation method for sensitive detection of enterovirus, rotavirus, hepatitis A virus, and small round structured viruses in water samples. Int J Food Microbiol (1997) 1.45
Effect of jaw-thrust and continuous positive airway pressure on tidal breathing in deeply sedated infants. J Pediatr (2001) 1.44
[Mumps epidemic in vaccinated children in West Switzerland]. Schweiz Med Wochenschr (1997) 1.42
Canine echinococcosis in Kyrgyzstan: using prevalence data adjusted for measurement error to develop transmission dynamics models. Int J Parasitol (2008) 1.32
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J Infect Dis (1997) 1.24
The risk of transmitting cytomegalovirus to patients receiving blood transfusions. J Infect Dis (1986) 1.23
Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus. J Clin Microbiol (1994) 1.20
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study. Swiss HIV Cohort Study. Infection (2000) 1.14
An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis (1996) 1.14
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol (1995) 1.12
Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica (1985) 1.09
Bochdalek diaphragmatic hernia: not only a neonatal disease. Arch Dis Child (2003) 1.08
Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. N Engl J Med (1985) 1.06
Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol (1998) 1.05
Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis. J Clin Microbiol (1995) 1.04
Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) (2001) 1.04
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol (1991) 1.04
Detection of mumps virus in clinical specimens by rapid centrifugation culture and conventional tube cell culture. J Virol Methods (1998) 1.02
Management of acute bronchiolitis: can evidence based guidelines alter clinical practice? Thorax (2008) 1.01
Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin. J Acquir Immune Defic Syndr (1991) 0.99
Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii. J Clin Microbiol (1996) 0.97
Evaluation of 2-SP transport medium for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by two automated amplification systems and culture for chlamydia. J Clin Pathol (1997) 0.95
Competitive polymerase chain reaction using an internal standard: application to the quantitation of viral DNA. J Virol Methods (1992) 0.95
Toxoplasmosis in pregnancy. Lancet (1994) 0.95
Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome. Br Med J (Clin Res Ed) (1983) 0.94
Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review. Clin Infect Dis (1997) 0.93
Detection of human immunodeficiency virus (HIV) type 1 antibodies by new automated microparticle enzyme immunoassay for HIV types 1 and 2. J Clin Microbiol (1995) 0.93
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
Epstein-Barr virus infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis (1993) 0.91
Immune response to Staphylococcus aureus in atopic dermatitis. Dermatologica (1985) 0.90
Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine (2001) 0.90
The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme. Eur J Epidemiol (1995) 0.90
Detection by PCR of enteroviruses in cerebrospinal fluid during a summer outbreak of aseptic meningitis in Switzerland. J Clin Microbiol (1998) 0.90
[Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Rev Epidemiol Sante Publique (1998) 0.89
Lemierre syndrome and nosocomial transmission of Fusobacterium necrophorum from patient to physician. Klin Padiatr (2010) 0.88
Adult bacterial nasopharyngitis: a clinical entity? J Gen Intern Med (1993) 0.87
Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol (2002) 0.85
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Schweiz Med Wochenschr (1998) 0.85
Association of admission L-lactate concentration in hospitalised equine neonates with presenting complaint, periparturient events, clinical diagnosis and outcome: a prospective multicentre study. Equine Vet J Suppl (2012) 0.85
Normal MRI findings in herpes simplex virus encephalitis. J Neurol (2000) 0.85
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study. Arch Intern Med (1998) 0.84
Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol (1987) 0.84
Virus inactivation during production of intravenous immunoglobulin. Transfusion (1991) 0.84
Outbreak of echovirus 30 meningitis in Switzerland. Scand J Infect Dis (1999) 0.84
IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins. J Virol Methods (1996) 0.84
Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Eur J Epidemiol (1997) 0.83
BCG osteomyelitis. Case report and review. Helv Paediatr Acta (1982) 0.83
Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr Infect Dis J (1996) 0.83
Myocardial infarction, culture-negative endocarditis, and Chlamydia pneumoniae infection: a dilemma? Clin Infect Dis (1999) 0.82
Familial glomerulopathy with giant fibrillar deposits. Virchows Arch A Pathol Anat Histol (1980) 0.82
A new mumps virus lineage found in the 1995 mumps outbreak in western Switzerland identified by nucleotide sequence analysis of the SH gene. Arch Virol (1996) 0.81
Anti-glucagon-cell and anti-adrenal-medullary-cell antibodies in islet-cell-autoantibody-positive diabetic children. N Engl J Med (1984) 0.81
Locked-in state in Borrelia burgdorferi meningitis. J Neurol (1989) 0.81
Acute tubulo-interstitial nephritis with uveitis (TINU syndrome) in a patient with serologic evidence for Chlamydia infection. Klin Wochenschr (1990) 0.81
Spontaneous and pokeweed mitogen-induced in vitro IgG production specific for S. aureus cell wall determinants in man. Clin Exp Immunol (1984) 0.79
[Increasing the immunization rate against measles, mumps, and rubella in medical students at the University of Berne]. Schweiz Med Wochenschr (1999) 0.79
Diabetes mellitus, endocrine autoantibodies, and prenatal rubella infection. Lancet (1982) 0.79
Visual and fine-motor outcomes in adolescent survivors of high-risk congenital diaphragmatic hernia who did not receive extracorporeal membrane oxygenation. J Perinatol (2009) 0.78
Distinct serum cytokine levels in drug- and measles-induced exanthema. Int Arch Allergy Immunol (1999) 0.78
Effects of acid proteinase inhibitors on human neutrophil chemotaxis and lysosomal enzyme release. II. Bromphenacyl bromide and 1,2-epoxy-3-(p-nitrophenoxy)propane. Clin Immunol Immunopathol (1983) 0.77
Abnormal humoral immune response to Staphylococcus aureus in patients with Staphylococcus aureus hyper IgE syndrome. Clin Exp Immunol (1986) 0.77
Immunoglobulin A-specific serodiagnosis of acute human cytomegalovirus infection by using recombinant viral antigens. J Clin Microbiol (1996) 0.76
Physical activity programs for promoting bone mineralization and growth in preterm infants. Cochrane Database Syst Rev (2007) 0.76
Islet-cell and insulin autoantibodies in first-degree relatives of type I diabetics: a 5-year follow-up study in a Swiss population. Adv Exp Med Biol (1988) 0.75
[Glomerulonephritis with transient C3 hypoclompimentemia and endotheliomesangial glomerulonephritis in childhood. A long-term experience]. Schweiz Med Wochenschr (1992) 0.75
[HIV diagnosis 1998]. Ther Umsch (1998) 0.75
Renal response to low-dose infusion of atrial natriuretic peptide in normal man. Kidney Int Suppl (1988) 0.75
[Pertussis in clinical practice--critical evaluation of diagnosis and epidemiology]. Schweiz Med Wochenschr (1992) 0.75
[Radiological lung changes during an influenza epidemic in 2 schools for Army recruits]. Schweiz Rundsch Med Prax (1987) 0.75
Cost-benefit analysis of hepatitis-B vaccination. A computerized decision model for Spain. Int J Technol Assess Health Care (1991) 0.75
[Current developments in Mycobacteria diagnosis]. Schweiz Med Wochenschr (1995) 0.75
[Viral respiratory infections in children: new diagnostic methods for early detection. Initial results of a pilot project in Switzerland]. Schweiz Med Wochenschr (1986) 0.75
[Virologic diagnosis: why? A partially prejudiced viewpoint]. Helv Paediatr Acta (1985) 0.75
Molecular and biochemical basis for the characterisation of antinuclear and anticytoplasmic antibodies. Clin Rheumatol (1987) 0.75
Acquired angioedema and anti-C1-inhibitor autoantibody. Arch Intern Med (1989) 0.75
[Epidemiology of HIV-1 infection in Bern--application of molecular methods]. Schweiz Med Wochenschr (1994) 0.75
[Metastazation into the seminal vesicles due to primary goblet cell carcinoid of the vermiform appendix. An unusual diagnostic procedure of a seminal vesicle tumor]. Urologe A (2009) 0.75
[Carotid artery dissection. Case examples and review]. Schweiz Med Wochenschr (1988) 0.75
Diagnosis by polymerase chain reaction of pneumonia caused by Legionella pneumophila in an immunocompetent child. Infection (1999) 0.75